Sangamo Therapeutics Announces Presentation At The Cowen And Company 37th Annual Health Care Conference
RICHMOND, Calif., March 1, 2017 /PRNewswire/ -- Sangamo Therapeutics, Inc. (Nasdaq: SGMO), the leader in therapeutic genome editing, announced today that Sandy Macrae, M.B., Ch.B., Ph.D., Sangamo's chief executive officer, will present at the Cowen and Company 37th Annual Health Care Conference on Wednesday, March 8th at 9:20 a.m. Eastern Time. The conference is being held in Boston from March 6-8, 2017.
The presentation will be webcast live and may be accessed via a link on the Sangamo Therapeutics website in the Investor Relations section under Events and Presentation. The presentation will be archived on the Sangamo website for two weeks after the event.
About Sangamo Therapeutics
Sangamo Therapeutics, Inc. is focused on translating ground-breaking science into genomic therapies that transform patients' lives using the company's industry leading platform technologies in genome editing, gene therapy, gene regulation and cell therapy. For more information about Sangamo, visit the Company's website at www.sangamo.com.
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/sangamo-therapeutics-announces-presentation-at-the-cowen-and-company-37th-annual-health-care-conference-300416191.html
SOURCE Sangamo Therapeutics, Inc.
Released March 1, 2017